In 2015 the Oregon Health Authority launched it’s Opioid Initiative, an integrated effort to address patient care and safety and population health during the opioid crisis. The initiative included public and private stakeholders engaged in 4 projects described in this report: a
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from West Virginia’s PDMP
The Washington legislature directed the medical associations in the state to develop opioid prescribing guidelines for their professions by 2019. This 4 page document briefly explains the guidelines developed for dentists. Funding Source: Washington State Department of Health
A toolkit prepared by the Veterans Health Administration to help primary care providers manage opioid tapering in their practices. It includes steps to take before beginning a taper including assessing the patient for conditions that might complicate the tapering process and communicating directly with the patient about opioid safety and tapering options.
This 2016 toolkit from Partnership Health Plan of California provides guidance for providers seeking to engage their patients in a step-wise, physician directed tapering of their opioid dose. The toolkit has 4 sections: how to identify candidates for tapering, how to collaboratively set a tapering plan with the patient, how to manage the tapering process and complications, and advice on planning for special situations
This 3 minute video explains the 2018 Washington State opioid prescribing guidelines for patients and caregivers. The video features the voices of pain patients and advocates. Funding Source: Washington State Department of Health
This 2018 report from the Prescription Drug Monitoring Program (PDMP) Training and Technical Assistance Center at Brandeis University describes the history of PDMPs in the United States. From the first program established in 1918 in New York through Supreme Court decisions until the 21st century when 49 states, the
This one page document summarizes the strategies health plans can use to reduce opioid overuse and misuse among their patient populations as described in the 2 California Health Care Foundation Reports. Funding Source: California Health Care Foundation
A 2016 report from the California Health Care Foundation on strategies health plans can adopt to address opioid overuse and misuse among their insured populations. The report provides examples of strategies in 4 areas: engaging providers, working with high-risk members, addressing misuse, and supporting healthy
This 2016 report profiles 3 California health plans that took aggressive actions to reduce opioid overuse and misuse among their patient populations and presents the results from their efforts. The report profiles the efforts of Partnership Health Plan of California, Blue Shield of California, and Kaiser Permanente Southern California. Prepared by the California Health Care Foundation. Funding Source: California Health Care Foundation